FI56012C - Foerfarande foer framstaellning av blodtrycksnedsaettande 1h-2,3,4,5-tetrahydroimidazo(2,1-b)kinazolin-2-oner och 1,2,3,4,5,6-hexahydropyrimido(2,1-b)kinazolin-2-oner - Google Patents

Foerfarande foer framstaellning av blodtrycksnedsaettande 1h-2,3,4,5-tetrahydroimidazo(2,1-b)kinazolin-2-oner och 1,2,3,4,5,6-hexahydropyrimido(2,1-b)kinazolin-2-oner

Info

Publication number
FI56012C
FI56012C FI240873A FI240873A FI56012C FI 56012 C FI56012 C FI 56012C FI 240873 A FI240873 A FI 240873A FI 240873 A FI240873 A FI 240873A FI 56012 C FI56012 C FI 56012C
Authority
FI
Finland
Prior art keywords
oner
blodtrycksnedsaettande
hexahydropyrimido
tetrahydroimidazo
quinazolin
Prior art date
Application number
FI240873A
Other languages
English (en)
Other versions
FI56012B (fi
Inventor
Jr Warren Neil Beverung
Richard Anthony Partyka
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI56012B publication Critical patent/FI56012B/fi
Application granted granted Critical
Publication of FI56012C publication Critical patent/FI56012C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI240873A 1972-09-22 1973-07-31 Foerfarande foer framstaellning av blodtrycksnedsaettande 1h-2,3,4,5-tetrahydroimidazo(2,1-b)kinazolin-2-oner och 1,2,3,4,5,6-hexahydropyrimido(2,1-b)kinazolin-2-oner FI56012C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29145072A 1972-09-22 1972-09-22

Publications (2)

Publication Number Publication Date
FI56012B FI56012B (fi) 1979-07-31
FI56012C true FI56012C (fi) 1979-11-12

Family

ID=23120338

Family Applications (1)

Application Number Title Priority Date Filing Date
FI240873A FI56012C (fi) 1972-09-22 1973-07-31 Foerfarande foer framstaellning av blodtrycksnedsaettande 1h-2,3,4,5-tetrahydroimidazo(2,1-b)kinazolin-2-oner och 1,2,3,4,5,6-hexahydropyrimido(2,1-b)kinazolin-2-oner

Country Status (6)

Country Link
CH (1) CH609348A5 (fi)
DK (1) DK152367C (fi)
FI (1) FI56012C (fi)
HU (1) HU167227B (fi)
NL (1) NL178165C (fi)
SE (1) SE407408B (fi)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598823A (en) * 1969-05-28 1971-08-10 Sandoz Ag Tricyclic quinazolinones
BE760013A (fr) * 1969-12-18 1971-06-08 Smith Kline French Lab Imidazo et pyrimido -(2,1-b)quinazolines, leurs procedes de preparationet compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
HU167227B (fi) 1975-09-27
FI56012B (fi) 1979-07-31
NL178165C (nl) 1986-02-03
CH609348A5 (en) 1979-02-28
SE407408B (sv) 1979-03-26
NL7310776A (fi) 1974-03-26
SE7310561L (fi) 1974-03-25
DK152367B (da) 1988-02-22
DK152367C (da) 1988-07-25

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE397257B (sv) Forfarande for framstellning av sackaroshaltiga sotningsmedel
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
NO139522C (no) Fremgangsmaate til fremstilling av deoksyamino-glycosid-antibiotika
SE414025B (sv) Forfarande for framstellning av fototropa flerfokala glasogonglas
SE395460B (sv) Forfarande for framstellning av 2beta,16beta-dipiperidino-5alfa-androstaner
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE396385B (sv) Forfarande for framstellning av n-benshydryl-n'-p-hydroxibensyl-piperaziner
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
AR197040A1 (es) Procedimiento de preparacion de nuevas bifenilacetamidas
SE385906B (sv) Forfarande for framstellning av kardenolid-3-(2'-desoxi-glykosider)
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe
IT996099B (it) Procedimento di preparazione di amminoantrachinone